NASDAQ:ANNX Annexon (ANNX) Stock Price, News & Analysis $3.41 -0.11 (-3.13%) Closing price 04:00 PM EasternExtended Trading$3.50 +0.09 (+2.79%) As of 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Annexon Stock (NASDAQ:ANNX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Annexon alerts:Sign Up Key Stats Today's Range$3.40▼$3.6650-Day Range$3.41▼$4.3352-Week Range$3.36▼$7.18Volume3.19 million shsAverage Volume3.05 million shsMarket Capitalization$650.51 millionP/E RatioN/ADividend YieldN/APrice Target$13.33Consensus RatingHold Company Overview Annexon is a clinical-stage biopharmaceutical company developing antibody-based therapies for diseases driven by the complement system, a part of the immune system involved in inflammation and tissue damage. The company focuses on the classical complement pathway, which it aims to inhibit selectively. Its investigational programs are designed for complement-related autoimmune, inflammatory and neurodegenerative conditions. These include treatments being studied for disorders affecting the nervous system and the eye. Annexon’s candidates remain in development and are not approved medicines. Founded in 2011, Annexon is headquartered in Brisbane, California. The company conducts clinical development and research to advance its antibody therapies.AI Generated. May Contain Errors. Read More Annexon Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreANNX MarketRank™: 3.052825552825 of 5 starsAnnexon scored higher than 61% of companies evaluated by MarketBeat, and ranked 619th out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingAnnexon has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 5 buy ratings, 2 hold ratings, and 2 sell ratings.Upside PotentialAnnexon has a consensus price target of $13.33, representing about 291.0% upside from its current price of $3.41.Amount of Analyst CoverageAnnexon has only been the subject of 2 research reports in the past 90 days.Read more about Annexon's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Annexon are expected to grow in the coming year, from ($1.03) to ($0.92) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Annexon is -3.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Annexon is -3.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAnnexon has a P/B Ratio of 4.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted17.05% of the float of Annexon has been sold short.Short Interest Ratio / Days to CoverAnnexon has a short interest ratio ("days to cover") of 7.19.Change versus previous monthShort interest in Annexon has recently decreased by 8.36%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAnnexon does not currently pay a dividend.Dividend GrowthAnnexon does not have a long track record of dividend growth. News and Social Media1.7 / 5News Sentiment-0.34 News SentimentAnnexon has a news sentiment score of -0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Annexon this week, compared to 4 articles on an average week.MarketBeat Follows2 people have added Annexon to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership3.2 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $99,829.00 in company stock, which represents 0.0153% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Annexon insiders have bought more of their company's stock than they have sold. Specifically, they have bought $99,829.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders10.31% of the stock of Annexon is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsAnnexon has minimal institutional ownership at this time.Read more about Annexon's insider trading history. Receive ANNX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Annexon and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ANNX Stock News HeadlinesHC Wainwright Predicts Annexon's Q4 Earnings (NASDAQ:ANNX)November 14, 2026 | americanbankingnews.comFY2029 Earnings Estimate for Annexon Issued By HC WainwrightNovember 13, 2026 | americanbankingnews.comI'm handing you this stock todayElon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.November 19 at 1:00 AM | Behind the Markets (Ad)Annexon, Inc. (NASDAQ:ANNX) Stock Has Consensus Price Target of $15.29November 12, 2026 | americanbankingnews.comAnnexon Reports Third Quarter 2026 Financial Results, Business Updates and Key Anticipated MilestonesNovember 9, 2026 | finance.yahoo.comAnnexon (ANNX) Projected to Announce Earnings on MondayNovember 8, 2026 | americanbankingnews.comAnnexon, Inc. (ANNX) Discusses Vonaprument Phase III ARCHER II Trial in Geographic Atrophy - SlideshowNovember 7, 2026 | seekingalpha.comAnnexon, Inc. (ANNX) Discusses Vonaprument Phase III ARCHER II Trial in Geographic Atrophy TranscriptNovember 3, 2026 | seekingalpha.comSee More Headlines ANNX Stock Analysis - Frequently Asked Questions How have ANNX shares performed this year? Annexon's stock was trading at $5.02 on January 1st, 2026. Since then, ANNX shares have decreased by 32.1% and is now trading at $3.41. How were Annexon's earnings last quarter? Annexon, Inc. (NASDAQ:ANNX) released its earnings results on Monday, November, 9th. The company reported ($0.25) earnings per share for the quarter, topping analysts' consensus estimates of ($0.28) by $0.03. When did Annexon IPO? Annexon (ANNX) raised $229 million in an IPO on Friday, July 24th 2020. The company issued 14,750,000 shares at a price of $15.00-$16.00 per share. J.P. Morgan, BofA Securities and Cowen acted as the underwriters for the IPO. Who are Annexon's major shareholders? Annexon's top institutional investors include State Street Corp (5.01%), Goldman Sachs Group Inc. (2.06%), Candriam S.C.A. (0.89%) and Marshall Wace LLP (0.83%). Insiders that own company stock include Muneer A Satter, Douglas Love, Michael Overdorf, Dean Richard Artis, Jennifer Lew, Ted Yednock, William H Carson, Jamie Dananberg and Jung Choi. View institutional ownership trends. How do I buy shares of Annexon? Shares of ANNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Annexon own? Based on aggregate information from My MarketBeat watchlists, some other companies that Annexon investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Viking Therapeutics (VKTX), SoundHound AI (SOUN), IonQ (IONQ), Joby Aviation (JOBY) and Applied Digital (APLD). Company Calendar Last Earnings11/09/2026Today11/19/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ANNX's financial health is in the Yellow zone, according to TradeSmith. ANNX has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:ANNX CIK1528115 Webwww.annexonbio.com Phone650-822-5500Fax650-636-9773Employees92Year Founded2011Price Target and Rating Average Price Target for Annexon$13.33 High Price Target$25.00 Low Price Target$3.00 Potential Upside/Downside+291.0%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)($1.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$206.69 million Net MarginsN/A Pretax MarginN/A Return on Equity-106.82% Return on Assets-76.75% Debt Debt-to-Equity Ratio0.35 Current Ratio5.79 Quick Ratio5.79 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.75 per share Price / Book4.55Miscellaneous Outstanding Shares190,764,000Free Float171,096,000Market Cap$650.51 million OptionableOptionable Beta1.43 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:ANNX) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Annexon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Annexon With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.